Convixion builds vertical AI platforms that transform complex industries through deep, specialized intelligence. We are pioneering the future of healthcare innovation with three powerful AI platforms: Convixion Trial Design Optimizer (Launching 2026) -Trained on over 500,000 real clinical trials. Helps MedTech and pharma teams design better protocols faster: optimize eligibility criteria, predict enrollment risks, reduce termination probability, and accelerate time-to-market. Convixion Diagnostics (In active development) We are building fine-tuned, interactive models for: -Brain tumor detection and classification -Diabetic retinopathy -Pneumonia and COVID-19 detection -Multi-disease lung classification -Melanoma and skin cancer detection Designed for easy, clinician-friendly access. Convixion MedTech – Deep intelligence for the full MedTech ecosystem: -AI-powered analysis of adverse event reports and drug safety data -Advanced search, analysis, and synthesis of clinical trial information -Instant review and summarization of biomedical literature -Comprehensive tracking of MedTech patents and innovation trends -Seamless provider lookup and credential verification Convixion also powers the world’s most extensive AI-driven securities research platform, delivering real-time entity tracking, market intelligence, and workflow acceleration for investment professionals. At Convixion, we don’t build general-purpose AI. We build deep, vertical, outcome-focused AI that moves industries forward. Healthcare innovators, MedTech founders, clinical teams--we’re here to help you go faster.
| Employees | 1 (0 on RocketReach) |
| Founded | 2025 |
| Industry | Business Consulting and Services |
Looking for a particular Convixion employee's phone or email?
Convixion Questions
